Adaptive Biotechnologies

aid: adaptive-biotechnologies
name: Adaptive Biotechnologies
description: 'Adaptive Biotechnologies Corporation (Nasdaq: ADPT) is a Seattle, Washington immune-medicine company that reads
  and translates the adaptive immune system at scale. Founded in 2009 by brothers Chad Robins and Harlan Robins as Adaptive
  TCR Corporation, it built an immunosequencing platform that amplifies and sequences rearranged T-cell and B-cell receptor
  genes, then applies computational models to turn that receptor repertoire into clinical and research data. Its lead commercial
  product is clonoSEQ, an FDA-cleared next-generation sequencing assay for measurable residual disease (MRD) in multiple myeloma,
  B-cell acute lymphoblastic leukemia, chronic lymphocytic leukemia, mantle cell lymphoma and diffuse large B-cell lymphoma,
  run out of its CLIA-certified, CAP-accredited Seattle laboratory. It also sells immunoSEQ research assays with the cloud-based
  immunoSEQ Analyzer and the immuneACCESS public data repository, and MRD biopharma services to drug developers. Adaptive
  is a diagnostics and services company, not a software vendor: it publishes no developer portal, no public API reference
  and no machine-readable specification. Its integration surface is clinician-facing and delivered bilaterally — clonoSEQ
  orders and results flow through Epic (including Epic Aura), Flatiron Health''s OncoEMR via Molecular Profiling Integration,
  and Carequality/health information exchanges, arranged through its EMR integration specialists rather than through self-serve
  documentation.'
url: https://raw.githubusercontent.com/api-evangelist/adaptive-biotechnologies/refs/heads/main/apis.yml
accessModel:
  pricing: unknown
  onboarding: unknown
  trial: false
  try_now: false
  public: false
  label: Unknown
  confidence: low
  probe_state: gated
  source:
  - rate-limits
  - security
  generated: '2026-11-06'
  method: derived
image: https://www.adaptivebiotech.com/wp-content/uploads/2021/01/adaptive-logo@2x-copy.png
x-type: company
x-source: harvest:secondary-market
x-tier: profiled
x-tier-reason: enrichment-pipeline
specificationVersion: '0.20'
created: '2026-09-07'
modified: '2026-09-07'
tags:
- Company
- Biotechnology
- Life Sciences
- Genomics
- Immunology
- Clinical Diagnostics
- Oncology
- Healthcare
- Laboratory
- Precision Medicine
- Data
tags_raw:
- Company
- Biotechnology
- Life Sciences
- Genomics
- Immunology
- Clinical Diagnostics
- Oncology
- Health Care
- Laboratory
- Precision Medicine
- Data
apis: []
maintainers:
- FN: Kin Lane
  email: kin@apievangelist.com
- FN: APIs.json
  email: info@apis.io
common:
- type: Plans
  url: plans/adaptive-biotechnologies-plans-pricing.yml
- type: RateLimits
  url: rate-limits/adaptive-biotechnologies-rate-limits.yml
- type: Conformance
  url: conformance/adaptive-biotechnologies-conformance.yml
- type: LLMsTxt
  url: llms/adaptive-biotechnologies-llms.txt
- type: DomainSecurity
  url: security/adaptive-biotechnologies-domain-security.yml
- type: Website
  url: https://www.adaptivebiotech.com/
- type: Support
  url: https://www.adaptivebiotech.com/contact-us/
- type: Blog
  url: https://www.adaptivebiotech.com/blog/
- type: Login
  url: https://clients.adaptivebiotech.com/login
- type: TermsOfService
  url: https://www.adaptivebiotech.com/terms-of-service/
- type: PrivacyPolicy
  url: https://www.adaptivebiotech.com/online-privacy-policy/
- type: Compliance
  url: https://www.adaptivebiotech.com/licenses-and-accreditation/
- type: Careers
  url: https://www.adaptivebiotech.com/career-listings/
- type: InvestorRelations
  url: https://investors.adaptivebiotech.com/
- type: SecondaryMarket
  url: https://forgeglobal.com/adaptive-biotechnologies_stock/
x-enrichment:
  date: '2026-09-07'
  status: minimal
  artifacts_added: 7
  pass: local-v3
x-coverage:
  state: gated
  reason: sales-gate
  detail: Adaptive markets a live clonoSEQ integration surface — "40+ direct data connections across 200+ healthcare institutions",
    Epic Aura, Flatiron OncoEMR Molecular Profiling Integration and Carequality result delivery — but the only door is an
    8-12 week engagement arranged with integration specialists at emrsupport@adaptivebiotech.com; there is no developer page
    in the 35-URL sitemap, no interface specification, and /openapi.json plus every named /.well-known path 404s on all four
    Adaptive-controlled hosts.
  evidence:
  - url: https://www.clonoseq.com/emr-integration/
    status: 200
  - url: https://clients.adaptivebiotech.com/login
    status: 200
  - url: https://www.adaptivebiotech.com/openapi.json
    status: 404
  - url: https://www.adaptivebiotech.com/.well-known/api-catalog
    status: 404
  - url: https://www.adaptivebiotech.com/page-sitemap.xml
    status: 200
  - url: https://api.github.com/orgs/AdaptiveBiotech/repos
    status: 200
  checked: '2026-09-07'